Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 12 studies | 28% ± 12% | |
| plasmacytoid dendritic cell | 6 studies | 21% ± 4% | |
| epithelial cell | 5 studies | 34% ± 14% | |
| endothelial cell | 4 studies | 22% ± 8% | |
| deuterosomal cell | 3 studies | 18% ± 1% | |
| pancreatic A cell | 3 studies | 31% ± 5% | |
| fibroblast | 3 studies | 20% ± 2% | |
| natural killer cell | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 505.20 | 1445 / 1445 | 100% | 10.32 | 183 / 183 |
| ovary | 100% | 730.43 | 180 / 180 | 100% | 17.87 | 430 / 430 |
| pancreas | 100% | 429.03 | 328 / 328 | 100% | 14.63 | 178 / 178 |
| prostate | 100% | 795.67 | 245 / 245 | 100% | 21.71 | 502 / 502 |
| stomach | 100% | 589.89 | 359 / 359 | 100% | 12.03 | 286 / 286 |
| thymus | 100% | 1182.24 | 653 / 653 | 100% | 39.98 | 605 / 605 |
| uterus | 100% | 540.79 | 170 / 170 | 100% | 16.55 | 459 / 459 |
| brain | 100% | 775.12 | 2641 / 2642 | 100% | 19.22 | 705 / 705 |
| kidney | 100% | 1093.24 | 89 / 89 | 100% | 15.78 | 900 / 901 |
| skin | 100% | 663.39 | 1809 / 1809 | 100% | 13.72 | 471 / 472 |
| adrenal gland | 100% | 1385.31 | 258 / 258 | 100% | 18.98 | 229 / 230 |
| liver | 100% | 470.50 | 226 / 226 | 100% | 11.02 | 404 / 406 |
| bladder | 100% | 562.71 | 21 / 21 | 99% | 15.90 | 501 / 504 |
| lung | 99% | 572.94 | 574 / 578 | 100% | 17.51 | 1155 / 1155 |
| intestine | 100% | 622.48 | 966 / 966 | 99% | 14.04 | 523 / 527 |
| breast | 100% | 717.64 | 459 / 459 | 99% | 17.82 | 1109 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 24.28 | 29 / 29 |
| spleen | 100% | 815.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.68 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.33 | 1 / 1 |
| adipose | 100% | 623.02 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 773.86 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 364.52 | 1320 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 11.20 | 79 / 80 |
| heart | 99% | 870.65 | 849 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 608.42 | 883 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016226 | Biological process | iron-sulfur cluster assembly |
| GO_0106035 | Biological process | protein maturation by [4Fe-4S] cluster transfer |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0051539 | Molecular function | 4 iron, 4 sulfur cluster binding |
| Gene name | ISCA2 |
| Protein name | Iron-sulfur cluster assembly 2 Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1) |
| Synonyms | HBLD1 |
| Description | FUNCTION: Involved in the maturation of mitochondrial 4Fe-4S proteins functioning late in the iron-sulfur cluster assembly pathway. May be involved in the binding of an intermediate of Fe/S cluster assembly. . |
| Accessions | ENST00000298818.12 ENST00000554924.1 [Q86U28-2] ENST00000556816.6 [Q86U28-1] J3QSS7 Q86U28 |
